Divi's Laboratories (DIVISLAB) — Financial Results

Divi's Laboratories reported a 25.5% YoY rise in Q3 FY25 net profit to ₹589 crores, driven by strong revenue growth to ₹2,401 crores, while operating margins declined to 31% from 37-38% due to regulatory costs and pricing pressure. The company targets double-digit growth amid strategic investments in its Kakinada facility, with Phase I commercialization expected in 6 months to enhance cost structure and supply reliability.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this financial results affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 7 February 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 7 February 2025

SBIN State Bank of India Financial Results RECLTD REC Limited Financial Results TITAN Titan Company Limited Financial Results BHARTIARTL Bharti Airtel Limited Financial Results BHARTIARTL Bharti Airtel Limited Financial Results BRITANNIA Britannia Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.